NEW Keiki Family Based Intervention to Combat Childhood Obesity

March 1, 2019 updated by: Malia Shimokawa, MD

N.E.W. Keiki - Nutrition + Exercise + Weight Management Programs: Family-based Intervention to Combat Childhood Obesity in Hawai'i

The purpose of this project is to create a database to collect information about the NEW Keiki Program. The information collected for this project will be used to evaluate the program. The NEW Keiki program promotes healthy lifestyles and behavior changes.

Study Overview

Status

Completed

Conditions

Detailed Description

A database containing pre and post program information will be developed. For the referred patients, this database will contain information related to the following:

  • Past medical history
  • Obesity-related Medical co-morbidities (HTN, hyperlipidemia, e.g.)
  • Lab values (fasting lipids, glucose, LFTs, HbA1c)
  • Anthropometric data (ht, weight, BMI) and select vital signs (BP, HR)
  • Fitness testing data
  • Demographic data (age, gender, ethnicity, socioeconomic status, geographical address)
  • Answers to a lifestyle, attitudes, and health habits survey
  • Answers to a program survey
  • Contact information for follow up

For participating family members (parents, grandparents, siblings, e.g.) this data base will contain information related to the following:

  • Past medical history
  • Obesity-related Medical co-morbidities (HTN, hyperlipidemia, e.g.)
  • Anthropometric data (ht, weight, BMI) and select vital signs (BP, HR)
  • Demographic data (age, gender, ethnicity, socioeconomic status, geographical address)
  • Answers to a lifestyle, attitudes, and health habits survey
  • Answers to a program survey
  • Contact information for follow up

Once the database is created a retrospective chart review will be done to collect data on patients that have completed the program. This information will be obtained from facility records and program records. Individuals who previously completed the program will be contacted and asked to provide consent to be included in the database. Only data from individuals who provide consent will be included in the database.

Participants in the program will be asked to provide consent when they enroll in the program or when they come for a follow up visit. Only data from individuals who provide consent will be included in the database.

Subjects will be followed to collect information on lifestyle maintenance and long term health outcomes.

The database will be queried regularly to provide information about the participants and program.

Descriptive statistics will be calculated to describe the study population pre and post program. Outcomes will be analyzed using appropriate statistical tests. Exploratory analysis will be conducted to detect trends.

Data will be stored in a secure location with limited access. All paper documents will be stored in a locked office in a locked cabinet. Electronic data will be stored on a limited access computer. The database will be password protected and encrypted.

All participants will be assigned a study ID number. The study ID will be used for transmission of data. Data collection forms will use the assigned study ID. All data that needs to be transmitted will be de-identified to the extent possible, password protected, and encrypted.

Study Type

Observational

Enrollment (Actual)

213

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hawaii
      • Honolulu, Hawaii, United States, 96826
        • Kapiolani Medical Center for Women and Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects will be participants or family members of participants in the NEW Keiki program.

Description

Inclusion Criteria:

  • current or past participant in the NEW Keiki program
  • participating family member
  • able to understand English

Exclusion Criteria:

  • do not meet inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Family-Based
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite measure of improvement in participant/family health to include change in Body Mass Index, Weight, Blood Pressure, Lab Values
Time Frame: minimum 1 year
Change in body mass index (BMI),change in weight, change in blood pressure (BP), change in lab values
minimum 1 year
Composite measure of improvement in participant/family health to include change in lifestyle survey
Time Frame: minimum 1 year
Change in lifestyle survey about diet/nutrition and behaviors
minimum 1 year
Composite measure of improvement in participant/family health to include change in fitness testing data
Time Frame: minimum 1 year
Change in fitness testing data
minimum 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Malia Shimokawa, MD, Kapiolani Medical Center for Women & Children

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

March 25, 2014

First Submitted That Met QC Criteria

February 19, 2016

First Posted (Estimate)

February 25, 2016

Study Record Updates

Last Update Posted (Actual)

March 5, 2019

Last Update Submitted That Met QC Criteria

March 1, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2013-075

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

3
Subscribe